Moreover, it has beat estimates in the trailing four quarters by 8.3%, on average.Let’s take a closer look at the factors that substantiate the company’s Zacks Rank #1 (Strong Buy).The company continues to gain from this system, which in turn bolsters overall performance.In third-quarter 2019, da Vinci procedures improved 20% globally compared with the prior-year quarter.